Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This study is to designed to test the role of complement in the late asthmatic response to
allergen challenge in mild asthma, as an indicator of the possible role of complement in the
broader asthmatic population.